Skip to content

Condensed Nanofat Grafting for Treatment of Androgenetic Alopecia

Condensed Nanofat Grafting for Treatment of Androgenetic Alopecia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03506503
Enrollment
10
Registered
2018-04-24
Start date
2019-02-27
Completion date
2020-05-01
Last updated
2021-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Androgenic Alopecia

Keywords

nanofat, hair loss, prp

Brief summary

Nowadays, multiple treatment modalities have been applied clinically to treat androgenic alopecia, such as Follicular unit transplantation(FUT), finasteride, platelet-rich plasma injection(PRP), etc. In this clinical trial, the investigators aim to analyze the effect of nanofat grafting on treating androgenic alopecia in male.

Detailed description

The investigators will treat the hair loss area of a patient by processed nanofat grafting. The participants were asked to come back 1、3、6、9、12 months after treatment for further follow-up. Before and after the treatment, the hair and follicular will be assessed subjectively by satisfaction assessment, dermatoscope.

Interventions

hair loss area will be treated by processed autologous Nanofat grafting

Sponsors

Jinan University Guangzhou
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Male patients with androgenic alopecia aging from 18 to 50. * No scars and wounds on the alopecia area. * No skin disease or serious cardiovascular disease. * Preoperative examinations remain healthy.

Exclusion criteria

* Serious chronic heart, liver, kidney, blood system disease * Allergic diseases, skin inflammation or wounds * Alopecia but not androgenic alopecia * Acute or chronic infection * Take anticoagulant drugs * Active vitiligo, psoriasis, systemic lupus erythematosus

Design outcomes

Primary

MeasureTime frameDescription
DermatoscopeBaseline and at1,3,6,9,12 months after the treatmentthe density of hair follicle and diameter of hair will be analized by dermatoscope before and after the treatment of Nanofat grafting.

Other

MeasureTime frameDescription
Satisfaction assessments1,3,6,12 months after treatmentthe satisfaction will be assessed after the treatment

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026